buyWeak
Saba Capital Management, L.P. bought $243k of BMEZ
owner at BlackRock Health Sciences Term Trust. 15,281 shares at an average of $15.87, traded Oct 14, 2024, filed Oct 15, 2024.
Conviction score
15Value
$243k
15,281 shares
Holdings after
20,686,197
+0% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +12Role10% owner
- +13Trade size$243k at market
- -5Relative to holdingsUnder 1% of holdings (0.1%)
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
- -5Outside holderA 10% owner who is not an officer or director
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001510281-24-000529, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 14, 2024 | POpen-market purchase Common Stockindirect: - | +15,281 | $15.87 | $243k | 20,686,197 | Oct 15, 2024 |
Related signals
Other insiders at BlackRock Health Sciences Term Trust and this insider’s other filings.
| Score | Side | Company | Insider | Value | Shares | Filed |
|---|---|---|---|---|---|---|
| 32Weak | buy | BMEZ BlackRock Health Sciences Term Trust | Saba Capital Management, L.P. owner | $1.0M | 64,716 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.